Cargando…
Targeting RNA G‐quadruplexes as new treatment strategy for C9orf72 ALS/FTD
The recent discovery of a pathogenic expansion of a (GGGGCC)(n) repeat in the C9orf72 gene in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) led to a burst of mechanistic discoveries. In this issue, Simone et al (2018) describe novel compounds targeting the G‐quadruplex (G‐Q)...
Autores principales: | Schludi, Martin H, Edbauer, Dieter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760851/ https://www.ncbi.nlm.nih.gov/pubmed/29175945 http://dx.doi.org/10.15252/emmm.201708572 |
Ejemplares similares
-
Specific biomarkers for C9orf72
FTD/ALS could expedite the journey towards effective therapies
por: Balendra, Rubika, et al.
Publicado: (2017) -
C9orf72 and the Care of the Patient With ALS or FTD: Progress and Recommendations After 10 Years
por: Roggenbuck, Jennifer
Publicado: (2020) -
Topology of a G-quadruplex DNA formed by C9orf72 hexanucleotide repeats associated with ALS and FTD
por: Zhou, Bo, et al.
Publicado: (2015) -
G‐quadruplex‐binding small molecules ameliorate C9orf72
FTD/ALS pathology in vitro and in vivo
por: Simone, Roberto, et al.
Publicado: (2017) -
Selective C9orf72 G-Quadruplex-Binding
Small Molecules Ameliorate Pathological Signatures of ALS/FTD Models
por: Cheng, Aifang, et al.
Publicado: (2022)